Literature DB >> 34425713

The GLP-1 receptor in airway inflammation in asthma: a promising novel target?

Ashley Y Wu1, R Stokes Peebles1,2,3,4.   

Abstract

Entities:  

Keywords:  Asthma; GLP-1; IL-33; ILC2

Mesh：

Substances：

Year:  2021        PMID： 34425713      PMCID： PMC8487967          DOI： 10.1080/1744666X.2021.1971973

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN： 1744-666X            Impact factor:   5.124


× No keyword cloud information.
  32 in total

1.  Long-term observational study on the impact of GLP-1R agonists on lung function in diabetic patients.

Authors:  Paola Rogliani; Maria Gabriella Matera; Luigino Calzetta; Nicola A Hanania; Clive Page; Immacolata Rossi; Aikaterini Andreadi; Angelica Galli; Angelo Coppola; Mario Cazzola; Davide Lauro
Journal:  Respir Med       Date:  2019-06-18       Impact factor: 3.415

2.  IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.

Authors:  Jochen Schmitz; Alexander Owyang; Elizabeth Oldham; Yaoli Song; Erin Murphy; Terril K McClanahan; Gerard Zurawski; Mehrdad Moshrefi; Jinzhong Qin; Xiaoxia Li; Daniel M Gorman; J Fernando Bazan; Robert A Kastelein
Journal:  Immunity       Date:  2005-11       Impact factor: 31.745

3.  Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology.

Authors:  Melissa H Bloodworth; Mark Rusznak; Connor C Pfister; Jian Zhang; Lisa Bastarache; Sandra Alvarez Calvillo; James D Chappell; Kelli L Boyd; Shinji Toki; Dawn C Newcomb; Matthew T Stier; Weisong Zhou; Kasia Goleniewska; Martin L Moore; Tina V Hartert; Kevin D Niswender; R Stokes Peebles
Journal:  J Allergy Clin Immunol       Date:  2018-04-17       Impact factor: 10.793

4.  Intratracheal GLP-1 receptor agonist treatment up-regulates mucin via p38 and exacerbates emphysematous phenotype in mucus hypersecretory obstructive lung diseases.

Authors:  Hirofumi Nohara; Ryunosuke Nakashima; Shunsuke Kamei; Haruka Fujikawa; Keiko Ueno-Shuto; Taisei Kawakami; Yuka Eto; Mary Ann Suico; Jian-Dong Li; Hirofumi Kai; Tsuyoshi Shuto
Journal:  Biochem Biophys Res Commun       Date:  2020-01-26       Impact factor: 3.575

Review 5.  cAMP regulation of airway smooth muscle function.

Authors:  Charlotte K Billington; Oluwaseun O Ojo; Raymond B Penn; Satoru Ito
Journal:  Pulm Pharmacol Ther       Date:  2012-05-24       Impact factor: 3.410

6.  Glucagon-like peptide-1 (GLP-1) reduces mortality and improves lung function in a model of experimental obstructive lung disease in female mice.

Authors:  Niels-Erik Viby; Marie S Isidor; Katrine B Buggeskov; Steen S Poulsen; Jacob B Hansen; Hannelouise Kissow
Journal:  Endocrinology       Date:  2013-10-03       Impact factor: 4.736

7.  GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting.

Authors:  Meike Körner; Martin Stöckli; Beatrice Waser; Jean Claude Reubi
Journal:  J Nucl Med       Date:  2007-05       Impact factor: 10.057

8.  Liraglutide attenuates lipopolysaccharide-induced acute lung injury in mice.

Authors:  Feng Zhou; Ying Zhang; Jing Chen; Xuemei Hu; Yancheng Xu
Journal:  Eur J Pharmacol       Date:  2016-10-15       Impact factor: 4.432

9.  Glucagon-Like Peptide 1 Receptor: A Novel Pharmacological Target for Treating Human Bronchial Hyperresponsiveness.

Authors:  Paola Rogliani; Luigino Calzetta; Barbara Capuani; Francesco Facciolo; Mario Cazzola; Davide Lauro; Maria Gabriella Matera
Journal:  Am J Respir Cell Mol Biol       Date:  2016-12       Impact factor: 6.914

10.  Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition.

Authors:  Toshio Suzuki; Yuji Tada; Santhi Gladson; Rintaro Nishimura; Iwao Shimomura; Satoshi Karasawa; Koichiro Tatsumi; James West
Journal:  Respir Res       Date:  2017-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.